First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers
Clinical trial NCT02978755 · COMPLETED
Trial details
- NCT number
- NCT02978755
- Sponsor
- GamaMabs Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-06-10
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.